Cardiology

Novel oral glucose lowering drugs cut risks in T2DM

(HealthDay)—For patients with type 2 diabetes, novel oral glucose lowering drugs (GLDs) are associated with reduced risks of all-cause mortality, cardiovascular disease (CVD), and hypoglycemia, compared with insulin use, ...

Cardiology

Diabetes requiring insulin tied to increased stroke risk in A-fib

(HealthDay)—For patients with atrial fibrillation (AF), diabetes requiring insulin, but not diabetes without insulin treatment, is associated with an increased risk of stroke/systemic embolism, according to a study published ...

Diabetes

Can protein plus exercise improve type 2 diabetes?

Exercise has been shown to improve the health of people with type 2 diabetes. But the benefits of exercise vary greatly between people, meaning some benefit more than others. Now, researchers from Massey University's School ...

Diabetes

Researchers devise new diabetes diagnostic tool

Researchers at University of Exeter have developed a new test to help diagnoses diabetes, which they say will lead to more effective diagnosis and patient care.

Diabetes

Novel mechanism of insulin resistance in type 2 diabetes

Insensitivity to insulin, also called insulin resistance, is associated with type 2 diabetes and affects several cell types and organs in the body. Now, scientists from Sweden's Karolinska Institutet have discovered a mechanism ...

Diabetes

Gender-based differences in glycemic control in T2DM

(HealthDay)—For patients with type 2 diabetes, there are gender-based differences in glycemic control and hypoglycemia after insulin treatment, according to research published in the June issue of Diabetes, Obesity and ...

Diabetes

Roux-en-Y surgery can reverse insulin treatment in T2DM

(HealthDay)—Roux-en-Y gastric bypass surgery (RYGB) strongly predicts insulin cessation after surgery in insulin-treated type 2 diabetes (I-T2D) patients, independent of weight loss, according to a study published online ...

Diabetes

Intensive insulin provides survival

Long-term follow-up of the DIGAMI 1 trial – a landmark study of type 2 diabetes in Sweden – shows that intensive insulin treatment prolonged life by more than 2 years in patients with diabetes after a heart attack, compared ...

page 4 from 7